Clinical Trials Browser

Phase 1/2 × OTHER_GOV × Breast Neoplasms × Clear all

NCT05359783 2025-03-28

MAGSNOW

Phase 1/2 Completed

Breast Neoplasms

NCT06788197 2025-03-26

A Study of SHR-A1811 and Fulvestrant, With or Without HS-10352, in Locally Advanced or Metastatic Breast Cancer Patients

Phase 1/2 Not yet recruiting

Breast Neoplasms

NCT05176080 2024-12-17

Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer

Phase 1/2 Terminated

Breast Neoplasms

NCT03518268 2019-01-17

Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase Inhibitor

Phase 1/2 Unknown

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT01939418 2017-10-03

Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer

Phase 1/2 Terminated

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00825682 2016-12-08

The Effect of Reflexology on Radiation-related Fatigue in Breast Cancer Patients

Phase 1/2 Completed

72 enrolled 8 charts

Breast Neoplasms, Fatigue, Parasomnias

NCT02781155 2016-05-24

Limiting Chemotherapy Side Effects by Using Moxa

Phase 1/2 Unknown

BreastClassical hematologyGastrointestinal

Anemia, Breast Neoplasms, Genital Neoplasms, Female, Neoplasms, Neutropenia, Thrombocytopenia, Colorectal Neoplasms